0001193125-23-127842.txt : 20230531 0001193125-23-127842.hdr.sgml : 20230531 20230428184058 ACCESSION NUMBER: 0001193125-23-127842 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adverum Biotechnologies, Inc. CENTRAL INDEX KEY: 0001501756 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 205258327 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 100 CARDINAL WAY CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: (650) 649-1004 MAIL ADDRESS: STREET 1: 100 CARDINAL WAY CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Avalanche Biotechnologies, Inc. DATE OF NAME CHANGE: 20100921 CORRESP 1 filename1.htm CORRESP

ADVERUM BIOTECHNOGIES, INC.

100 Cardinal Way

Redwood City, California 94063-6548

April 28, 2023

VIA EMAIL AND EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Mail Stop 3720

Washington, D.C. 20549

Attn: Doris Gama

 

RE:

Adverum Biotechnogies, Inc.

Registration Statement on Form S-3

File No. 333-271431

Ladies and Gentlemen:

Adverum Biotechnogies, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on May 2, 2023, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable thereafter.

Once the Registration Statement has been declared effective, please orally confirm that event with Kenneth Guernsey of Cooley LLP, counsel to the Registrant, at (415) 693-2091, or in his absence, Brett White at (650) 843-5191.

 

Very truly yours,
ADVERUM BIOTECHNOGIES, INC.
By:   /s/ Linda Rubinstein
Name:   Linda Rubinstein
Title:   Chief Financial Officer

 

cc:

John Rakow, General Counsel, Adverum Biotechnogies, Inc.

Kenneth Guernsey, Cooley LLP

Brett White, Cooley LLP